Accumetrics launches bedside diagnostic tool

Article

Cardiovascular diagnostic device developer Accumetrics has begun shipping its Ultegra point-of-care diagnostic system, designed to measure platelet function in patients undergoing coronary interventional procedures. The portable device can assess

Cardiovascular diagnostic device developer Accumetrics has begun shipping its Ultegra point-of-care diagnostic system, designed to measure platelet function in patients undergoing coronary interventional procedures. The portable device can assess platelet function at the bedside from a whole blood sample in less than two minutes, according to the San Diego-based company, and enables cardiologists to measure the effects of certain inhibitors in the cardiac cath lab. The Ultegra system is intended to serve as a platform for other point-of-care diagnostic applications Accumetrics intends to bring to market, according to Terry Johnson, president and CEO.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.